Orphenadrine Citrate Extended-Release Tablets Rx

Select the drug indication to add to your list

Orphenadrine Citrate Extended-Release Tablets

Musculoskeletal pain
Only 4 drugs may be compared at once

Generic Name and Formulations:

Orphenadrine citrate 100mg; sust-rel tabs.

Select therapeutic use:

Indications for Orphenadrine Citrate Extended-Release Tablets:

Painful musculoskeletal conditions.


100mg twice daily (AM and PM).


Not recommended.


Glaucoma. Achalasia. GU or GI obstruction. Myasthenia gravis.


Coronary disease, insufficiency, or arrhythmias. Asthma (inj). Monitor blood, urine, and liver in long-term use. Pregnancy (Cat.C). Nursing mothers.

See Also:

Orphenadrine Injection

Pharmacological Class:



Potentiates anticholinergics, alcohol, other CNS depressants, MAOIs, antidepressants. Tremors, mental confusion with propoxyphene. Antagonizes steroids, barbiturates, phenylbutazone.

Adverse Reactions:

Tachycardia, transient dizziness or syncope, other anticholinergic effects (eg, weakness, increased intraocular pressure, urinary retention, blurred vision, dry mouth), GI upset.


Formerly known under the brand name Norflex.

How Supplied:

Contact supplier